Mechanical Ventilator Adjustments and Patient Dyspnea

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBeth Israel Deaconess Medical Center

About this trial

In the past 5 years, there are increasing data suggesting that patients treated with mechanical ventilation experience shortness of breath, despite appropriate sedation. This adverse experience is believed to contribute to the finding that up to 25% of patients who survive severe respiratory diseases experience mental health problems including post traumatic distress syndrome (PTSD). The purpose of this study is to evaluate if/how sequential changes in the delivery of mechanical ventilation affect shortness of breath sensation in awake patients requiring mechanical ventilation. Improving the knowledge of the impact of the patient-ventilator interaction on shortness of breath sensation may lead to strategies to improve the comfort of non-sedated and sedated ventilated patients, and thereby reduce mental health sequelae in survivors of acute severe respiratory diseases The investigators hypothesize that current ventilator strategies, particularly reduced tidal volume (size of breath given by the ventilator) utilized in managing patients with severe respiratory diseases, contribute to shortness of breath in patients with increased drive to breathe. In this setting, some safe ventilator changes may improve or worsen the shortness of breath sensation in awake patients on mechanical ventilation.

Eligibility criteria

Qualifiers

Admitted to a participating ICU at BIDMC

Requiring mechanical ventilation

Awake by both of the following criteria

RASS -2 to +2*

Disqualifiers

Age < 18 years old

Comfort measures only

Hemodynamic instability (MAP < 65 mmHg) or increasing requirement of vasopressor

PEEP > 10 cmH2O

Trial design

Treatments tested in this trial

  • Change to VC/AC
  • Change in Tidal Volume
  • Change in inspiratory flow
  • Change in PEEP
  • Change to PSV

Treatment groups

20 Participants
are divided into 1 treatment group